Reference
Shih L-Y, et al. Emerging kinetics of BCR-ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure. Leukemia Research 37: 43-49, No. 1, Jan 2013. Available from: URL: http://doi.org/10.1016/j.leukres.2012.09.012 - Taiwan
Rights and permissions
About this article
Cite this article
Dasatinib/imatinib/nilotinib. Reactions Weekly 1499, 13 (2014). https://doi.org/10.1007/s40278-014-0494-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-0494-5